Citigroup
FTH icon

Citigroup’s Faeth Therapeutics FTH Stock Holding History

Citigroup’s Portfolio FTH Stock Details FTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$165K Buy
+5,559
New +$173K ﹤0.01% 4294
2026
Q1 		– Sell
-294
Closed -$3.14K – 6367
2025
Q4 		$3.14K Buy
+294
New +$2.84K ﹤0.01% 5368
2025
Q2 		– Sell
-6
Closed -$49 – 5893
2025
Q1 		$49 Buy
+6
New +$57 ﹤0.01% 5452
2022
Q4 		– Sell
-18
Closed -$1K – 5941
2022
Q3 		$1K Sell
18
-16
-47% -$629 ﹤0.01% 5686
2022
Q2 		$2K Sell
34
-72
-68% -$2.7K ﹤0.01% 5918
2022
Q1 		$5K Sell
106
-215
-67% -$17.1K ﹤0.01% 5836
2021
Q4 		$37K Buy
321
+201
+168% +$30K ﹤0.01% 5206
2021
Q3 		$25K Buy
120
+102
+567% +$18.6K ﹤0.01% 5137
2021
Q2 		$4K Sell
18
-7
-28% -$1.73K ﹤0.01% 5882
2021
Q1 		$7K Buy
+25
New +$8.37K ﹤0.01% 5813

Other funds holding FTH

Candriam SCA
Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return
RIS
Richmond Investment Services Mequon, Wisconsin $316M AUM 19.72% 1-Year Est. Return
China Universal Asset Management Company
China Universal Asset Management Company Shanghai, China $1.92B AUM 74.14% 1-Year Est. Return
State of Wyoming
State of Wyoming Cheyenne, Wyoming $1.29B AUM 32.25% 1-Year Est. Return
Financial Consulate
Financial Consulate Hunt Valley, Maryland $899M AUM 14.82% 1-Year Est. Return
Physician Wealth Advisors
Physician Wealth Advisors Midvale, Utah $869M AUM 17.6% 1-Year Est. Return
Fortitude Family Office
Fortitude Family Office Scottsdale, Arizona $586M AUM 20.58% 1-Year Est. Return
SBI Securities
SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return

Citigroup's FTH Position: Q3 2026 in Review

Citigroup opened a new position in Faeth Therapeutics (FTH) in Q3 2026: 5,559 shares worth $165K. The stake represents ﹤0.01% of the portfolio and ranks #4294 among its holdings. This is a return to the name: Citigroup previously reported a position in FTH as recently as Q4 2025.

Citigroup first reported a position in FTH in Q1 2021 and has held it in 10 quarters since. 9 funds tracked by Wall St. Rank hold FTH as of Q3 2026.

  • Citigroup held 5,559 shares of Faeth Therapeutics worth $165K as of Q3 2026.
  • Faeth Therapeutics was a new Citigroup position in Q3 2026.
  • Faeth Therapeutics made up ﹤0.01% of Citigroup's portfolio in Q3 2026, its #4294 holding.
  • Citigroup first reported a position in Faeth Therapeutics in Q1 2021 and has held it in 10 quarters since.
  • 9 funds tracked by Wall St. Rank held Faeth Therapeutics as of Q3 2026.

Based on Citigroup's 13F filing for Q3 2026, filed 4 Nov 2026.